P1-185 P-T03A-1187
Biomaterials for theranostics -
Biomaterials for cancer therapy
Targeted delivery of multiresponsive mesoporous manganese dioxide coated nanotherapeutics for chemo/chemodynamic therapies against colorectal cancer
Xiang-Yun Song
|
P1-186 E-T03A-1349
Biomaterials for theranostics -
Biomaterials for cancer therapy
Biodegradable block copolymers incorporating tyrosinate groups demonstrate a highly effective capability for in vivo mRNA delivery
Yuki Nakashima
|
P1-187 P-T03A-3183
Biomaterials for theranostics -
Biomaterials for cancer therapy
Aptamer-modified, biomimetic peptide amphiphile micelles for targeted hematological cancer treatment
Agustin Barcellona
|
P1-188 P-T03A-1386
Biomaterials for theranostics -
Biomaterials for cancer therapy
Engineered hetero nanostructures for photocatalysis-mediated intratumoral H2S splitting and drug-free colon cancer therapy
Arjun Sabu
|
P1-189 O-T03A-2829
Biomaterials for theranostics -
Biomaterials for cancer therapy
Synthetic bone marrow niches for testing novel leukaemia therapies
William Sebastian Doherty-Boyd
|
P1-190 O-T03C-2319
Biomaterials for theranostics -
Drug delivery
Polymeric adapalene-loaded nanospheres targeting skin layers and hair follicles
Bozena Michniak-Kohn
|
P1-191 E-T03B-3076
Biomaterials for theranostics -
Biomaterials for molecular imaging
Stiffness of Collagen-I Micro-Forms in Ventricular Myocardium
Ken Webb
|
P1-192 O-T03C-1966
Biomaterials for theranostics -
Drug delivery
Nano lipid carrier-based targeted combinatorial nanoformulations loaded gel for the effective treatment of skin cancer
Nazeer Hasan
|
P1-193 O-T03C-3111
Biomaterials for theranostics -
Drug delivery
Trojan horse for targeted therapy of kidney cancer
Olga Sindeeva
|
P1-194 P-T03A-0139
Biomaterials for theranostics -
Biomaterials for cancer therapy
Activatable chemodynamic therapy – the HULK system
HULIN JIANG
|
P1-195 O-T03A-0312
Biomaterials for theranostics -
Biomaterials for cancer therapy
Designing nanomedicines for breast cancer therapy
Amarnath P. Rajendran
|
P1-196 E-T03A-1112
Biomaterials for theranostics -
Biomaterials for cancer therapy
A novel anti-inflammatory oxaliplatin (IV) prodrug nanomedicine to enhance colorectal cancer therapy
Lei Xing
|
P1-197 O-T03C-2821
Biomaterials for theranostics -
Drug delivery
Novel drug delivery systems for regenerative medicine applications for perspective valorization of agricultural-derived waste products
Irene Carmagnola
|
P1-198 E-T03A-2927
Biomaterials for theranostics -
Biomaterials for cancer therapy
Self-Assembled Carbon Dots in Bioapplications
Yu-Fen Huang
|
P1-199 E-T03A-3216
Biomaterials for theranostics -
Biomaterials for cancer therapy
One stone two birds strategy based on nano-photosensitizers constructed via a non-cyanine dye for deep NIR excited PDT and PTT
dawei jiang
|
P1-200 O-T03C-3645
Biomaterials for theranostics -
Drug delivery
Development of hydrogel vascular surrogates for molecular diffusional studies
Rosaire Mongrain
|
P1-201 O-T03A-0350
Biomaterials for theranostics -
Biomaterials for cancer therapy
Atomic-Level Modulation of Functional Metal Nanomaterials for Tumor-Specific Therapy
Xi Hu
|
P1-202 P-T03A-2062
Biomaterials for theranostics -
Biomaterials for cancer therapy
Using micelle-coated radioisotope-labeled antibody to improve the hepatocellular carcinoma treatment efficacy
Yi-Ling Chen
|
P1-203 E-T03A-1644
Biomaterials for theranostics -
Biomaterials for cancer therapy
Studies into Cancer Tissue Stiffness and Immune Therapy Effectiveness: Convergence of 3D Printing and T-Cells
Mahdiyeh Nouri Goushki
|
P1-204 P-T03A-1764
Biomaterials for theranostics -
Biomaterials for cancer therapy
ATP-Responsive Manganese-Based Bacterial Materials Selectively and Synergistically Activate the cGAS-STING Pathway for Tumor Immunotherapy
Huang Yang
|
P1-205 P-T03A-0088
Biomaterials for theranostics -
Biomaterials for cancer therapy
Synergistic Immunomodulation through Dual Antibody Therapy Targeting CD47 and CD24 for Enhanced Antitumor Immunity in Glioblastoma
Jonghoon Ha
|
P1-206 P-T03A-2590
Biomaterials for theranostics -
Biomaterials for cancer therapy
Nano-bio interface effect of graphene oxide boosted CAR-T cells against diverse refractory leukemia
Yan Wang
|
P1-207 O-T03A-1299
Biomaterials for theranostics -
Biomaterials for cancer therapy
Hyaluronic Acid-Coated Silver Nanoparticles Releasing Doxorubicin for Combinatorial Antitumor Therapy
Thi Phuong Le
|
P1-208 E-T03A-2022
Biomaterials for theranostics -
Biomaterials for cancer therapy
Harnessing 3D biomaterials-based osteosarcoma model for personalized therapy
Jeehee Lee
|
P1-209 E-T03A-2279
Biomaterials for theranostics -
Biomaterials for cancer therapy
Nanogalvanic control of magnesium degradation by-products for cancer therapy
Viviana M. Posada
|
P1-210 P-T03C-4158
Biomaterials for theranostics -
Drug delivery
Development of a Polyethyleneimine-Modified Methylcellulose Nanocarrier for Doxorubicin Delivery to Cancer Cells
Kitae Ryu
|
P1-211 P-T03H-4235
Biomaterials for theranostics -
Nucleic acid therapeutics
Cholesterol-incorporated mRNA for enhancing lipid nanoparticles (LNPs)-mediated mRNA delivery efficiency
Choeun Park
|
P1-212 P-T03C-4164
Biomaterials for theranostics -
Drug delivery
Intravital imaging of nanoparticle accumulation in a peripheral nerve injury model within neural tissue
Hsuan-Ju Chen
|
P1-213 P-T03G-4246
Biomaterials for theranostics -
Nano-biomaterials
One-pot synthesis of fluorescent polydopamine nanoparticles inspired by melanogenesis in nature
Haejin Jeong
|
P1-214 P-T03A-4221
Biomaterials for theranostics -
Biomaterials for cancer therapy
Tumor targeted ROS-sensitizing metal laden Polymeric Nanoparticles
Geum Byeol Park
|